Effects of the co-administration of budesonide on the plasma exposure of cabazitaxel (Jevtana) in hormone-refractory prostate cancer patients.
Phase of Trial: Phase I
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Cabazitaxel (Primary) ; Budesonide; Prednisone
- Indications Prostate cancer
- Focus Pharmacokinetics
- 24 Dec 2015 Status changed from active, no longer recruiting to completed as per Netherlands Trial Register record.
- 22 Apr 2012 Interim results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 22 Apr 2012 Status changed from planning to active, no longer recruiting.